The population genetics of antibiotic resistance: Integrating molecular mechanisms and treatment contexts

Nature Reviews Genetics

Volumn 11, Issue 6, 2010, Pages 405-414

  MacLean, R Craig ^a   Hall, Alex R ^a   Perron, Gabriel G ^a   Buckling, Angus ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; BACTERIAL GROWTH; GENE MUTATION; MOLECULAR EVOLUTION; MOLECULAR MECHANICS; NONHUMAN; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW; ANIMAL; BACTERIAL INFECTION; BIOLOGICAL MODEL; GENETICS; HUMAN; MICROBIOLOGY; SIGNAL TRANSDUCTION; SYNTHESIS; SYSTEM ANALYSIS;

BACTERIA (MICROORGANISMS);

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; GENETICS, POPULATION; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; SYSTEMS INTEGRATION;

EID: 77952556349     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2778     Document Type: Review

References (129)

1. Palumbi, S. R. Evolution\humans as the world's greatest evolutionary force. Science 293, 1786-1790 (2001).
2. Maynard Smith, J., Feil, E. J. & Smith, N. H. Population structure and evolutionary dynamics of pathogenic bacteria. Bioessays 22, 1115-1122 (2000).
3. Levy, S. B. & Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nature Med. 10, S122-S129 (2004).
4. Lipsitch, M. The rise and fall of antimicrobial resistance. Trends Microbiol. 9, 438-444 (2001).
5. Levin, B. R., Perrot, V. & Walker, N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154, 985-997 (2000).
6. Buckling, A., MacLean, R. C., Brockhurst, M. & Colegrave, N. The Beagle in a bottle. Nature 457, 824-829 (2009).
7. Gagneux, S. et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312, 1944-1946 (2006).
8. Nagaev, I., Bjorkman, J., Andersson, D. I. & Hughes, D. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol. Microbiol. 40, 433-439 (2001).
9. Rozen, D. E., McGee, L., Levin, B. R. & Klugman, K. P. Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 51, 412-416 (2007).
10. MacLean, R. C. & Buckling, A. The distribution of fitness effects of beneficial mutations in Pseudomonas aeruginosa. PLoS Genet. 5, e1000406 (2009).
11. Thomas, V. L., McReynolds, A. C. & Shoichet, B. K. Structural bases for stability-function tradeoffs in antibiotic resistance. J. Mol. Biol. 396, 47-59 (2010).
12. Wang, X. J., Minasov, G. & Shoichet, B. K. Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J. Mol. Biol. 320, 85-95 (2002).
13. Weinreich, D. M., Delaney, N. F., DePristo, M. A. & Hartl, D. L. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312, 111-114 (2006).
14. Michel, J. B., Yeh, P. J., Chait, R., Moellering, R. C. & Kishony, R. Drug interactions modulate the potential for evolution of resistance. Proc.Natl Acad. Sci. USA 105, 14918-14923 (2008).
15. Yeh, P. J., Hegreness, M. J., Aiden, A. P. & Kishony, R. Drug interactions and the evolution of antibiotic resistance. Nature Rev. Microbiol. 7, 460-466 (2009).
16. Perron, G. G., Gonzalez, A. & Buckling, A. Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost. Proc. R. Soc. Lond., B 274, 2351-2356 (2007).
17. Perron, G. G., Gonzalez, A. & Buckling, A. The rate of environmental change drives adaptation to an antibiotic sink. J. Evol. Biol. 21, 1724-1731 (2008).
18. Palmer, A. C., Angelino, E. & Kishony, R. hemical decay of an antibiotic inverts selection for resistance. Nature Chem. Biol. 6, 105-107.
19. Bollenbach, T., Quan, S., Chait, R. & Kishony, R. Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139, 707-718 (2009).
20. Walsh, C. Molecular mechanisms that confer antibacterial drug resistance. Nature 406, 775-781 (2000).
21. Andersson, D. I. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr. Opin. Microbiol. 9, 461-465 (2006).
22. Andersson, D. I. & Levin, B. R. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2, 489-493 (1999).
23. Bjorkman, J., Hughes, D. & Andersson, D. I. Virulence of antibiotic-resistant Salmonella typhimurium. Proc. Natl Acad. Sci. USA 95, 3949-3953 (1998).
24. Maisnier-Patin, S. & Andersson, D. I. Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res. Microbiol. 155, 360-369 (2004).
25. Andersson, D. I. & Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nature Rev. Microbiol. 8, 260-271 (2010).
26. Sandgren, A. et al. Tuberculosis drug resistance mutation database. PLoS Med. 6, e2 (2009).
27. Orr, H. A. The genetic theory of adaptation: a brief history. Nature Rev. Genet. 6, 119-127 (2005).
28. Eyre-Walker, A. & Keightley, P. D. The distribution of fitness effects of new mutations. Nature Rev. Genet. 8, 610-618 (2007).
29. Joyce, P., Rokyta, D. R., Beisel, C. J. & Orr, H. A. A general extreme value theory model for the adaptation of DNA sequences under strong selection and weak mutation. Genetics 180, 1627-1643 (2008).
30. Orr, H. A. The population genetics of adaptation: the adaptation of DNA sequences. Evolution 56, 1317-1330 (2002).
31. Orr, H. A. The distribution of fitness effects among beneficial mutations. Genetics 163, 1519-1526 (2003).
32. Gillespie, J. H. A simple stochastic gene substitution model. Theor. Popul. Biol. 23, 202-215 (1983).
33. Kassen, R. & Bataillon, T. Distribution of fitness effects among beneficial mutations before selection in experimental populations of bacteria. Nature Genet. 38, 484-488 (2006).
34. Sanjuan, R., Moya, A. & Elena, S. F. The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc. Natl Acad. Sci. USA 101, 8396-8401 (2004).
35. Baquero, F., Negri, M. C., Morosini, M. L. & Blázquez, J. Selection of very small differences in bacterial evolution. Int. Microbiol. 1, 295-300 (1998).
36. Drlica, K. The mutant selection window and antimicrobial resistance. J. Antimicrob. Chemother. 52, 11-17 (2003).
37. Fischbach, M. A. & Walsh, C. T. Antibiotics for emerging pathogens. Science 325, 1089-1093 (2009).
38. LeClerc, J. E., Li, B., Payne, W. L. & Cebula, T. A. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 1208-1211 (1996).
39. Matic, I. et al. Highly variable mutation rates in commensal and pathogenic Escherichia coli. Science 277, 1833-1834 (1997).
40. Oliver, A., Cantón, R., Campo, P., Baquero, F. & Blázquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-1253 (2000).
41. Giraud, A., Radman, M., Matic, I. & Taddei, F. The rise and fall of mutator bacteria. Curr. Opin. Microbiol. 4, 582-585 (2001).
42. Lind, P. A. & Andersson, D. I. Whole-genome mutational biases in bacteria. Proc. Natl Acad. Sci. USA 105, 17878-17883 (2008).
43. Garibyan, L. et al. Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair 2, 593-608 (2003).
44. Ochman, H., Lawrence, J. G. & Grolsman, E. A. Lateral gene transfer and the nature of bacterial innovation. Nature 405, 299-304 (2000).
45. Hanage, W. P., Fraser, C., Tang, J., Connor, T. R. & Corander, J. Hyper-recombination, diversity, and antibiotic resistance in pneumococcus. Science 324, 1454-1457 (2009).
46. Mazel, D. Integrons: agents of bacterial evolution. Nature Rev. Microbiol. 4, 608-620 (2006).
47. Martinez, J. L. The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc. R. Soc. Lond., B 276, 2521-2530 (2009).
48. Turner, P. E. Phenotypic plasticity in bacterial plasmids. Genetics 167, 9-20 (2004).
49. Levin, B. R., Stewart, F. M. & Rice, V. A. The kinetics of conjugative plasmid transmission: fit of a simple mass action model. Plasmid 2, 247-260 (1979).
50. Dionisio, F., Matic, I., Radman, M., Rodrigues, O. R. & Taddei, F. Plasmids spread very fast in heterogeneous bacterial communities. Genetics 162, 1525-1532 (2002).
51. Lilley, A. K. & Bailey, M. J. The transfer dynamics of Pseudomonas sp. plasmid pQBR11 in biofilms. FEMS Microbiol. Ecol. 42, 243-250 (2002).
52. D'Costa, V. M., McGrann, K. M., Hughes, D. W. & Wright, G. D. Sampling the antibiotic resistome. Science 3 11, 374-377 (2006).
53. Sommer, M. O., Dantas, G. & Church, G. M. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325, 1128-1131 (2009).
54. Perron, G. G., Quessy, S. & Bell, G. A reservoir of drug-resistant pathogenic bacteria in asymptomatic hosts. PLoS ONE 3, e3749 (2008).
55. Burt, A. & Trivers, R. Genes in Conflict (Belknap, Cambridge, Massachusetts, 2006).
56. Dionisio, F., Conceição, I. C., Marques, A. C. R., Fernandes, L. & Gordo, I. The evolution of a conjugative plasmid and its ability to increase bacterial fitness. Biol. Lett. 1, 250-252 (2005).
57. Luciani, F., Sisson, S. A., Jiang, H. L., Francis, A. R. & Tanaka, M. M. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 106, 14711-14715 (2009).
58. Devanas, M. A., Rafaeli-Eshkol, D. & Stotzky, G. Survival of plasmid-containing strains of Escherichia coli in soil: effect of plasmid size and nutrients on survival of hosts and maintenance of plasmids. Curr. Microbiol. 13, 269-277 (1986).
59. Bouma, J. E. & Lenski, R. E. Evolution of a bacteria/plasmid association. Nature 335, 351-352 (1988).
60. Dahlberg, C. & Chao, L. Amelioration of the cost of conjugative plasmid carriage in Escherichia coli K12. Genetics 165, 1641-1649 (2003).
61. Modi, R. I. & Adams, J. Coevolution in bacterial-plasmid populations. Evolution 45, 656-667 (1991).
62. Enne, V. I., Delsol, A. A., Roe, J. M. & Bennett, P. M. Rifampicin resistance and its fitness cost in Enterococcus faecium. J. Antimicrob. Chemother. 53, 203-207 (2004).
63. Kugelberg, E., Lofmark, S., Wretlind, B. & Andersson, D. I. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 55, 22-30 (2005).
64. Mariam, D. H., Mengistu, Y., Hoffner, S. E. & Andersson, D. I. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48, 1289-1294 (2004).
65. Trindade, S. et al. Positive epistasis drives the acquisition of multidrug resistance. PLoS Genet. 5, e1000578 (2009).
66. Tokuriki, N., Stricher, F., Schymkowitz, J., Serrano, L. & Tawfik, D. S. The stability effects of protein mutations appear to be universally distributed. J. Mol. Biol. 369, 1318-1332 (2007).
67. Blance, S. J. et al. Temperature-sensitive suppressor mutations of the Escherichia coli DNA gyrase B protein. Protein Sci. 9, 1035-1037 (2000).
68. Guerois, R., Nielsen, J. E. & Serrano, L. Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J. Mol. Biol. 320, 369-387 (2002).
69. Potapov, V., Cohen, M. & Schreiber, G. Assessing computational methods for predicting protein stability upon mutation: good on average but not in the details. Protein Eng. Des. Sel. 22, 553-560 (2009).
70. Perkins, A. E. & Nicholson, W. L. Uncovering new metabolic capabilities of Bacillus subtilis using phenotype profiling of rifampin-resistant rpoB mutants. J. Bacteriol. 190, 807-814 (2008).
71. Hall, A. R., Griffiths, V. F., MacLean, R. C. & Colegrave, N. Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa. Proc. R. Soc. Lond., B 277, 643-650 (2010).
72. Hanson, D. K., Tiede, D. M., Nance, S. L., Chang, C. H. & Schiffer, M. Site-specific and compensatory mutations imply unexpected pathways for proton delivery to the QB binding-site of the photosynthetic reaction-center. Proc. Natl Acad. Sci. USA 90, 8929-8933 (1993).
73. Reynolds, M. G. Compensatory evolution in rifampin-resistant Escherichia coli. Genetics 156, 1471-1481 (2000).
74. Björkman, J., Hughes, D. & Andersson, D. I. Virulence of antibiotic-resistant Salmonella typhimurium. Proc. Natl Acad. Sci. USA 95, 3949-3953 (1998).
75. Maisnier-Patin, S., Paulander, W., Pennhag, A. & Andersson, D. I. Compensatory evolution reveals functional interactions between ribosomal proteins S12 L14 and L19. J. Mol. Biol. 366, 207-215 (2007).
76. Nilsson, A. I. et al. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proc. Natl Acad. Sci. USA 103, 6976-6981 (2006).
77. Romero, D. & Palacios, R. Gene amplification and genomic plasticity in prokaryotes. Annu. Rev. Genet. 31, 91-111 (1997).
78. Sandegren, L. & Andersson, D. I. Bacterial gene amplification: implications for the evolution of antibiotic resistance. Nature Rev. Microbiol. 7, 578-588 (2009).
79. Rokyta, D., Badgett, M. R., Molineux, I. J. & Bull., J. J. Experimental genomic evolution: extensive compensation for loss of DNA ligase activity in a virus. Mol. Biol. Evol. 19, 230-238 (2002).
80. Sherman, D. R. et al. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272, 1641-1643 (1996).
81. Andersson, D. I. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6, 452-456 (2003).
82. Schrag, S. J., Perrot, V. & Levin, B. R. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. R. Soc. Lond., B 264, 1287-1291 (1997).
83. Orr, H. A. The population genetics of adaptation: the distribution of factors fixed during adaptive evolution. Evolution 52, 935-949 (1998).
84. Gillespie, J. H. Molecular evolution over the mutational landscape. Evolution 38, 1116-1129 (1984).
85. Bjorkman, J., Nagaev, I., Berg, O. G., Hughes, D. & Andersson, D. I. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287, 1479-1482 (2000).
86. Maisnier-Patin, S., Berg, O. G., Liljas, L. & Andersson, D. I. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol. Microbiol. 46, 355-366 (2002).
87. Moore, F. B. G., Rozen, D. E. & Lenski, R. E. Pervasive compensatory adaptation in Escherichia coli. Proc. R. Soc. Lond., B 267, 515-522 (2000).
88. Schoustra, S. E., Bataillon, T., Gifford, D. R. & Kassen, R. The properties of adaptive walks in evolving populations of fungus. PLoS Biol. 7, e1000250 (2009).
89. Paulander, W., Maisnier-Patin, S. & Andersson, D. I. Multiple mechanisms to ameliorate the fitness burden of mupirocin resistance in Salmonella typhimurium. Mol. Microbiol. 64, 1038-1048 (2007).
90. DePristo, M. A., Weinreich, D. M. & Hartl, D. L. Missense meanderings in sequence space: a biophysical view of protein evolution. Nature Rev. Genet. 6, 678-687 (2005).
91. Poon, A., Davis, B. H. & Chao, L. The coupon collector and the suppressor mutation: estimating the number of compensatory mutations by maximum likelihood. Genetics 170, 1323-1332 (2005).
92. Smith, P. A. & Romesberg, F. E. Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation. Nature Chem. Biol. 3, 549-556 (2007).
93. Hauser, A. R. Antibiotics Basics for Clinicians: Choosing the Right Antibacterial Agent, 318 (Lippincott Williams and Wilkins, Baltimore, 2007).
94. Hegreness, M., Shoresh, N., Damian, D., Hartl, D. & Kishony, R. Accelerated evolution of resistance in multidrug environments. Proc. Natl Acad. Sci. USA 105, 13977-13981 (2008).
95. Ward, H., Perron, G. & MacLean, R. C. The fitness cost of multiple drug resistance in Pseudomonas aeruginosa. J. Evol. Biol. 22, 997-1003 (2009).
96. Anderson, J. B., Ricker, N. & Sijursingh, C. Antagonism between two mechanisms of antifungal drug resistance. Eukaryotic Cell 5, 1243-1251 (2006).
97. Sanjuan, R., Cuevas, J. M., Moya, A. & Elena, S. F. Epistasis and the adaptability of an RNA virus. Genetics 170, 1001-1008 (2005).
98. Kemper, N. Veterinary antibiotics in the aquatic and terrestrial environment. Ecol. Indic. 8, 1-13 (2008).
99. Débarre, F., Lenormand, T. & Gandon, S. Evolutionary epidemiology of drug-resistance in space. PLoS Comput. Biol. 5, e1000337 (2009).
100. Harris, S. R. et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 327, 469-474 (2010).
101. Grundmann, H., Aires-de-Sousa, M., Boyce, J. & Tiemersma, E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368, 874-885 (2006).
102. Séveno, N. A. et al. Occurrence and reservoirs of antibiotic resistance genes in the environment. Rev. Med. Microbiol. 13, 15-27 (2002).
103. Perron, G. G., Bell, G. & Quessy, S. Parallel evolution of multidrug-resistance in Salmonella enterica isolated from swine. FEMS Microbiol. Lett. 281, 17-22 (2008).
104. Perron, G. G., Quessy, S., Letellier, A. & Bell, G. Genotypic diversity and antimicrobial resistance in asymptomatic Salmonella enterica serotype Typhimurium DT104. Infect. Genet. Evol. 7, 223-228 (2007).
105. Sexton, T., Clarke, P., O'Neill, E., Dillane, T. & Humphreys, H. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: correlation with patient isolates and implications for hospital hygiene. J. Hosp. Infect. 62, 187-194 (2006).
106. Sánchez-Payá, J. et al. Nosocomial infection surveillance and control: current situation in Spanish hospitals. J. Hosp. Infect. 72, 50-56 (2009).
107. Seppala, H. et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337, 441-446 (1997).
108. Pal, C., Macia, M. D., Oliver, A., Schachar, I. & Buckling, A. Coevolution with viruses drives the evolution of bacterial mutation rates. Nature 450, 1079-1081 (2007).
109. Perron, G. G. & Buckling, A. Hypermutability and compensatory adaptation in antibiotic-resistant bacteria. Am. Nat. (in the press).
110. Bergstrom, C. T., Lo, M. & Lipsitch, M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc. Natl Acad. Sci. USA 101, 13285-13290 (2004).
111. Smith, D. L., Dushoff, J., Perencevich, E. N., Harris, A. D. & Levin, S. A. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc. Natl Acad. Sci. USA 101, 3709-3714 (2004).
112. Martinez, J. L., Baquero, F. & Andersson, D. I. Predicting antibiotic resistance. Nature Rev. Microbiol. 5, 958-965 (2007).
113. Campbell, E. A. et al. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104, 901-912 (2001).
114. Johanson, U., Ævarsson, A., Liljas, A. & Hughes, D. The dynamic structure of EF-G. studied by fusidic acid resistance and internal revertants. J. Mol. Biol. 258, 420-432 (1996).
115. Madigan, M. T. & Martinko, J. M. Brock Biology of Microorganisms, (Pearson Education, San Francisco, 2006).
116. Cohan, F. M., King, E. C. & Zawadzki, P. Amelioration of the deleterious pleiotropic effects of an adaptive mutation in Bacillus subtilis. Evolution 48, 81-95 (1994).
117. Austin, D. J. & Anderson, R. M. Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Philos. Trans. R. Soc. Lond., B 354, 721-738 (1999).
118. De Gelder, L. et al. Combining mathematical models and statistical methods to understand and predict the dynamics of antibiotic-sensitive mutants in a population of resistant bacteria during experimental evolution. Genetics 168, 1131-1144 (2004).
119. Reluga, T. C. Simple models of antibiotic cycling. Math. Med. Biol. 22, 187-208 (2005).
120. Martin, G., Lenormand, T. & Phillips, P. A general multivariate extension of Fisher's geometric model and the distribution of mutation fitness effects across species. Evolution 60, 893-907 (2009).
121. Rokyta, D. R. et al. Beneficial fitness effects are not exponential for two viruses. J. Mol. Evol. 67, 368-376 (2008).
122. Szathmáry, E. Do deleterious mutations interact synergistically? Metabolic control theory provides a partial answer. Genetics 133, 127-132 (1993).
123. Klipp, E. et al. Systems Biology, (Wiley, Weinheim, Germany, 2009).
124. Sanjuan, R. & Nebot, M. R. A network model for the correlation between epistasis and genomic complexity. PLoS ONE 3, e2663 (2008).
125. Smith, E. E. et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl Acad. Sci. 103, 8487-8492 (2006).
126. Meacci, F. et al. Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient. J. Clin. Microbiol. 43, 3114-3120 (2005).
127. Mwangi, M. M. et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl Acad. Sci. USA 104, 9451-9456 (2007).
128. Lipsitch, M., Bergstrom, C. T. & Levin, B. R. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc. Natl Acad. Sci. USA 97, 1938-1943 (2000).
129. Brown, E. M. & Nathwani, D. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J. Antimicrob. Chemother. 55, 6-9 (2005).